background findings british study suggest preconceptional paternal external radiation dose NUMBER msv NUMBER rem significantly related risk leukemia lymphoma offspring suggestion supported experimental epidemiologic studies purpose purpose study investigate preconceptional irradiation males females internally deposited radionuclides affects mortality risk developing cancer offspring methods offspring NUMBER females n NUMBER NUMBER males n NUMBER lived longer NUMBER year receiving thorotrast compound longer use cerebral arteriography studied mortality rate risk developing cancer thorotrast used contrast medium containing NUMBER colloidal solution thorium NUMBER alpha radionuclide retained lifelong nearly organs offspring exposed patients identified manual linkage municipal population registers vital status computerized linkage danish national central population registry incidence cancer computerized linkage danish national cancer registry standardized ratios smrs death incidence cancer offspring calculated ratios observed rates study population expected rates general population results median NUMBER years cases cancer breast uterine cervix melanoma skin retinoblastoma versus NUMBER cases expected developed NUMBER children born mothers received injections thorotrast smr NUMBER NUMBER confidence interval ci cases cancer case cancer lung testis thyroid hodgkins lymphoma cases melanoma skin versus NUMBER expected occurred NUMBER children exposed fathers smr NUMBER NUMBER ci case leukemia lymphoma occurred offspring studied mortality lower expected children exposed mothers smr NUMBER NUMBER ci exposed fathers smr NUMBER NUMBER ci conclusions study does support previously proposed association parental exposure radiation risk childhood leukemia lymphoma furthermore mortality causes increased offspring results support belief preconceptional parental exposure alpha radiation increases incidence cancer mortality offspring case control non hodgkins dioxide th particle emitting followed site specific follow NUMBER NUMBER NUMBER NUMBER non hodgkins NUMBER NUMBER NUMBER NUMBER low dose mortality morbidity